Gary P Jeffrey
Overview
Explore the profile of Gary P Jeffrey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
1500
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dart S, Prosser A, Huang W, Liu L, Lucas A, Delriviere L, et al.
Transplantation
. 2022 Dec;
107(7):1502-1512.
PMID: 36584373
Background: During solid organ transplantation, donor leukocytes, including myeloid cells, are transferred within the organ to the recipient. Both tolerogenic and alloreactive roles have been attributed to donor myeloid cells;...
12.
Maharaj A, Lubel J, Lam E, Clark P, Duncan O, George J, et al.
Hepatol Commun
. 2022 Sep;
6(11):3260-3271.
PMID: 36153817
Although there are several established international guidelines on the management of hepatocellular carcinoma (HCC), there is limited information detailing specific indicators of good quality care. The aim of this study...
13.
Barreto S, Strasser S, McCaughan G, Fink M, Jones R, McCall J, et al.
Cancers (Basel)
. 2022 Jun;
14(11).
PMID: 35681757
Background: Expansion in liver transplantation (LT) criteria for HCC from Milan to UCSF has not adversely impacted overall survival, prompting further expansion towards Metroticket 2.0 (MT2). In this study, we...
14.
Janjua M, Knuiman M, Divitini M, McQuillan B, Olynyk J, Jeffrey G, et al.
Hepatol Commun
. 2021 Dec;
6(3):526-534.
PMID: 34931492
Low-level alcohol consumption is associated with reduced cardiovascular disease (CVD) in the general population. It is unclear whether this association is seen in patients with nonalcoholic fatty liver disease (NAFLD)...
15.
Wang Z, Bertot L, Jeffrey G, Joseph J, Garas G, De Boer B, et al.
Clin Gastroenterol Hepatol
. 2021 Oct;
20(9):2041-2049.e5.
PMID: 34624564
Background & Aims: Metabolic dysfunction-associated fatty liver disease (MAFLD) is managed predominately in primary care, however, there is uncertainty regarding how to best identify patients for specialist referral. We examined...
16.
Carter H, Jeffrey G, Ramm G, Gordon L
Value Health
. 2021 Oct;
24(10):1454-1462.
PMID: 34593168
Objectives: Risk-stratified ultrasound screening for hepatocellular carcinoma (HCC), informed by a serum biomarker test, enables resources to be targeted to patients at the highest risk of developing cancer. We aimed...
17.
Prosser A, Huang W, Liu L, Dart S, Watson M, De Boer B, et al.
Cell Rep
. 2021 May;
35(7):109141.
PMID: 34010637
The heterogeneous pool of tissue-resident lymphocytes in solid organs mediates infection responses and supports tissue integrity and repair. Their vital functions in normal physiology suggest an important role in solid...
18.
Wang Z, Huang Y, Nossent H, Chan J, Adams L, Joseph J, et al.
JGH Open
. 2020 Dec;
4(6):1211-1216.
PMID: 33319058
Background And Aim: Methotrexate (MTX) is routinely used for immunological disorders, and its long-term use is associated with hepatotoxicity. The aim of this study was to investigate whether a serum...
19.
Lim H, Jeffrey G, Ramm G, Soekmadji C
Front Cell Infect Microbiol
. 2020 Nov;
10:587628.
PMID: 33240824
Extracellular vesicles are encapsulated lipid nanoparticles secreted by a variety of cell types in living organisms. They are known to carry proteins, metabolites, nucleic acids, and lipids as their cargoes...
20.
Davis T, Peters K, Chubb S, Adams L, Jeffrey G, Davis W
J Clin Med
. 2020 Oct;
9(11).
PMID: 33114323
Objective: To determine whether the incidence/outcome of hepatobiliary disease (HBD) has increased over recent decades in community-based Australians with and without type 2 diabetes (T2D). Methods: Longitudinal data from the...